Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes
- 17 September 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 198 (3) , 369-377
- https://doi.org/10.1002/path.1224
Abstract
The objective of this study was to determine the expression and production of antimicrobial peptides by healthy and inflamed human synovial membranes. Deposition of the antimicrobial peptides lysozyme, lactoferrin, secretory phospholipase A2 (sPA2), matrilysin (MMP7), human neutrophil alpha-defensins 1–3 (HNP 1–3), human beta-defensin 1 (HBD-1), and human beta-defensin 2 (HBD-2) was determined by immunohistochemistry. Expression of mRNA for the antimicrobial peptides bactericidal permeability-increasing protein (BPI), heparin binding protein (CAP37), human cationic antimicrobial protein (LL37), human alpha-defensin 5 (HD5), human alpha-defensin 6 (HD6), HBD-1, HBD-2, and human beta-defensin 3 (HBD-3) was analysed by reverse transcription polymerase chain reaction (RT-PCR). RT-PCR revealed CAP37 and HBD-1 mRNA in samples of healthy synovial membrane. Additionally, HBD-3 and/or LL37 mRNA was detected in synovial membrane samples from patients with pyogenic arthritis (PA), osteoarthritis (OA) or rheumatoid arthritis (RA). BPI, HD5, HD6, and HBD-2 mRNAs were absent from all samples investigated. Immunohistochemistry identified lysozyme, lactoferrin, sPA2, and MMP7 in type A synoviocytes of all samples. HBD-1 was only present in type B synoviocytes of some of the samples. Immunoreactive HBD-2 peptide was only visible in some inflamed samples. HNP1-3 was detected in both healthy and inflamed synovial membranes. The data suggest that human synovial membranes produce a broad spectrum of antimicrobial peptides. Under inflammatory conditions, the expression pattern changes, with induction of HBD-3 in PA (LL37 in RA; HBD-3 and LL37 in OA) as well as down-regulation of HBD-1. HBD-3 holds therapeutic potential in PA as it has a broad spectrum of antimicrobial activity and accelerates epithelial healing. However, caution is appropriate since defensins also promote fibrin formation and cell proliferation — key elements in joint infection. Clarification of the role of antimicrobial peptides in OA and RA will require further investigation. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 44 references indexed in Scilit:
- Expression of Natural Peptide Antibiotics in Human Articular Cartilage and Synovial MembraneClinical and Diagnostic Laboratory Immunology, 2001
- Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activityThe FASEB Journal, 2001
- Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide AntibioticJournal of Biological Chemistry, 2001
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- Peptide Antibiotics and Their Role in Innate ImmunityAnnual Review of Immunology, 1995
- Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian CellsAnnual Review of Immunology, 1993
- Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.Annals of the Rheumatic Diseases, 1990
- Localisation of lysozyme mRNA in rheumatoid synovial membrane by in situ hybridisation.Annals of the Rheumatic Diseases, 1989
- Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.Journal of Clinical Investigation, 1989
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.The Journal of cell biology, 1988